The Faculty has released an updated statement regarding the role of steroids in pain intervention techniques during the current COVID-19 pandemic.
The statement is available here.
Our previous recommendations FPM & BPS Joint Guidance on Pain Interventions during the COVID- 19 Recovery Phase (8 June 2020) published jointly with the BPS still stand. We however recommend that risk benefit ratio is also measured in the context of the local prevalence of the COVID-19 virus at that point in time.
For more pain-related COVID-19 resources, see our Evolving challenges hub.